Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Okponanabofa Eradiri"'
Autor:
Okponanabofa Eradiri, Susan Cady, Johannes Krämer, David Curran, James DeMuth, Erika S. Stippler, John Shabushnig, Vivian A. Gray, Munir A. Hussain
Publikováno v:
Dissolution Technologies. 25:8-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1a8c07a547011eb7cc7ea428dd53a92
https://doi.org/10.14227/dt250418p8
https://doi.org/10.14227/dt250418p8
Autor:
Todd R. Palmby, Jeannette Dinin, Laleh Amiri-Kordestani, Pengfei Song, Xiao Hong Chen, Kirsten B. Goldberg, Anamitro Banerjee, Fang Li, Reena Philip, William F. Pierce, Jingyu Yu, Shenghui Tang, Gideon M. Blumenthal, Sharon L. Kelly, Anuradha Ramamoorthy, Amna Ibrahim, Rosane Charlab, Julia A. Beaver, Gwynn Ison, Wimolnut Manheng, Vadryn Pierre, Soma Ghosh, Lynn J. Howie, Richard Pazdur, Lijun Zhang, Rajeshwari Sridhara, Eunice Y. Lee, Okponanabofa Eradiri, Hisani N. Horne, Paul G. Kluetz, Kumar G. Janoria, Kaushalkumar Dave
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(17)
The FDA approved niraparib, a poly(ADP-ribose) polymerase (PARP) inhibitor, on March 27, 2017, for maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response to platinum-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bdd1a690ce0c0bfffb01dc0f06f308d
https://pubmed.ncbi.nlm.nih.gov/29871906
https://pubmed.ncbi.nlm.nih.gov/29871906
Autor:
Okponanabofa Eradiri, Kamal K. Midha
Publikováno v:
Pharmaceutical Research. 12:2071-2074
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c5f125038ff81a5758deccbdfa140e2
https://doi.org/10.1023/a:1016241317260
https://doi.org/10.1023/a:1016241317260
Publikováno v:
Current medical research and opinion. 23(7)
To assess bioequivalence of two once-daily formulations of tramadol (T) as well as delineate pharmacokinetics of its enantiomers and those of its main metabolites after single- and multiple-dose administration.Single- and multiple-dose studies were c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1922c128b8e596c7ded2309f6476b1b5
https://pubmed.ncbi.nlm.nih.gov/17559753
https://pubmed.ncbi.nlm.nih.gov/17559753
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 852(1-2)
A stereospecific method for simultaneous quantitation of the enantiomers of tramadol (T) and its active metabolites O-demethyl tramadol (M1) and O-demethyl-N-demethyl tramadol (M5) in human plasma is reported. After the addition of penbutolol (IS), p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72529d6b3e5d43f2542838513088b35
https://pubmed.ncbi.nlm.nih.gov/17257910
https://pubmed.ncbi.nlm.nih.gov/17257910
Autor:
Okponanabofa Eradiri, Suryanarayana Sista, John C. K. Lai, Oanh H. Nguyen, Peter H. Silverstone
Publikováno v:
Current Medical Research & Opinion; Jul2007, Vol. 23 Issue 7, p1593-1604, 12p
Publikováno v:
Biopharmaceutics & Drug Disposition. 9:219-227
The influence of prednisone(PR), sulfasalazine(SZ), cimetidine(CM), and phenobarbital(PB) on the pharmacokinetics of metronidazole was investigated in six Crohn's patients. Metronidazole was first administered alone (250 mg bid, po) and then with pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48309c8699e9837a365bd70bfd1b6720
https://doi.org/10.1002/bod.2510090210
https://doi.org/10.1002/bod.2510090210